Literature DB >> 24984797

In vitro antibacterial activities of a thiazolyl peptide antibiotic PM2409.

Koteppa Pari1, Girish B Mahajan1, Vijayaphanikumar Yemparala1, Rajendra Kshirsagar1, Rajashri Parab1, Prashant Shanbhag1, Becky Thomas1, M Manisha1, Venkat Manohar1, H Sivaramakrishnan1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24984797     DOI： 10.1038/ja.2014.88

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  7 in total

1.  Discovery of LFF571: an investigational agent for Clostridium difficile infection.

Authors:  Matthew J LaMarche; Jennifer A Leeds; Adam Amaral; Jason T Brewer; Simon M Bushell; Gejing Deng; Janetta M Dewhurst; Jian Ding; JoAnne Dzink-Fox; Gabriel Gamber; Akash Jain; Kwangho Lee; Lac Lee; Troy Lister; David McKenney; Steve Mullin; Colin Osborne; Deborah Palestrant; Michael A Patane; Elin M Rann; Meena Sachdeva; Jian Shao; Stacey Tiamfook; Anna Trzasko; Lewis Whitehead; Aregahegn Yifru; Donghui Yu; Wanlin Yan; Qingming Zhu
Journal:  J Med Chem       Date:  2012-02-23       Impact factor: 7.446

2.  Antimicrobial activities of chemically modified thiazolyl peptide antibiotic MDL 62,879 (GE2270A).

Authors:  S Lociuro; P Tavecchia; E Marzorati; P Landini; B P Goldstein; M Denaro; R Ciabatti
Journal:  J Antibiot (Tokyo)       Date:  1997-04       Impact factor: 2.649

3.  Structure of an EF-Tu complex with a thiazolyl peptide antibiotic determined at 2.35 A resolution: atomic basis for GE2270A inhibition of EF-Tu.

Authors:  S E Heffron; F Jurnak
Journal:  Biochemistry       Date:  2000-01-11       Impact factor: 3.162

4.  Multiple mechanisms of action for inhibitors of histidine protein kinases from bacterial two-component systems.

Authors:  J J Hilliard; R M Goldschmidt; L Licata; E Z Baum; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

5.  Nocathiacin I analogues: synthesis, in vitro and in vivo biological activity of novel semi-synthetic thiazolyl peptide antibiotics.

Authors:  B Narasimhulu Naidu; Margaret E Sorenson; Yunhui Zhang; Oak K Kim; John D Matiskella; John A Wichtowski; Timothy P Connolly; Wenying Li; Kin S Lam; Joanne J Bronson; Michael J Pucci; Junius M Clark; Yasutsugu Ueda
Journal:  Bioorg Med Chem Lett       Date:  2004-11-15       Impact factor: 2.823

6.  In vitro and in vivo activities of antibiotic PM181104.

Authors:  Girish Mahajan; Becky Thomas; Rajashri Parab; Zarine E Patel; Sandip Kuldharan; Vijayaphanikumar Yemparala; Prabhu Dutt Mishra; Prafull Ranadive; Lisette D'Souza; Koteppa Pari; H Sivaramkrishnan
Journal:  Antimicrob Agents Chemother       Date:  2013-08-12       Impact factor: 5.191

7.  Kocurin, the true structure of PM181104, an anti-methicillin-resistant Staphylococcus aureus (MRSA) thiazolyl peptide from the marine-derived bacterium Kocuria palustris.

Authors:  Jesús Martín; Thiciana da S Sousa; Gloria Crespo; Sara Palomo; Ignacio González; José R Tormo; Mercedes de la Cruz; Matthew Anderson; Russell T Hill; Francisca Vicente; Olga Genilloud; Fernando Reyes
Journal:  Mar Drugs       Date:  2013-02-04       Impact factor: 5.118
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.